SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended		261 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011
REVENUES	$ 0	$ 0	$ 0	$ 0	$ 224,732
COST OF SALES	0	0	0	0	18,297
GROSS PROFIT	0	0	0	0	206,435
OPERATING EXPENSES
Professional fees	63,806	96,967	117,992	144,322	5,533,774
Research and development	0	0	10,870	0	1,984,028
Stock based compensation	0	0	984,975	0	984,975
Selling, general and administrative	59,156	7,164	101,243	14,405	2,980,459
Total Operating Expenses	122,962	104,131	1,215,080	158,727	11,483,236
LOSS FROM OPERATIONS	(122,962)	(104,131)	(1,215,080)	(158,727)	(11,276,801)
OTHER INCOME (EXPENSE)
Interest income	0	0	0	0	40,195
Interest expense	(5,038)	(3,058)	(9,390)	(5,852)	(697,327)
Gain (loss) on foreign currency exchange	0	9,389	0	15,413	(9,099)
Loss on cash deposit	0	0	0	0	(10,020)
Gain on settlement of debt	0	0	0	0	1,579,834
Total Other Income (Expense)	(5,038)	6,331	(9,390)	9,561	903,583
NET LOSS BEFORE PROVISION FOR INCOME TAX	(128,000)	(97,800)	(1,224,470)	(149,166)	(10,373,218)
PROVISION FOR INCOME TAX	0	0	0	0	0
NET LOSS	$ (128,000)	$ (97,800)	$ (1,224,470)	$ (149,166)	$ (10,373,218)
BASIC AND DILUTED LOSS PER SHARE	$ (0.02)	$ (0.01)	$ (0.18)	$ (0.02)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING -BASIC AND DILUTED	6,704,572	6,682,072	6,699,072	6,682,072